Lymphoma Hub Symposium
Europe | Lymphoma Hub
16 Jun, 2026

Optimizing treatment for chronic lymphocytic leukemia with BTK inhibitors

Monday, June 22, 2026

20:00 BST (21:00 CEST)

Join us for this informative session chaired by Gilles Salles and featuring distinguished experts Susan O’Brien, Farrukh Awan, and Francesc Bosch. This educational activity will enhance your understanding of the clinically relevant differences between BTK inhibitors, and their implications for treatment of chronic lymphocytic leukemia. Participants will also gain insights into treatment selection and key clinical data supporting BTK inhibitor-based treatment strategies for first-line and relapsed/refractory CLL.

To register, visit: https://virtual-symposium.lymphomahub.com/

our last news
on twitter

ELI Follow

The European Lymphoma Institute

Avatar
Retweet on Twitter ELI Retweeted
Avatar André Marc @marcandre64 ·
17 Nov 2023

Happy to see our paper about long term results of the H10 trial for early stage Hodgkin lymphoma. Fantastic collaboration for LYSA with FIL and EORTC.

Reply on Twitter 1725583785398280502 Retweet on Twitter 1725583785398280502 5 Like on Twitter 1725583785398280502 23 Twitter 1725583785398280502
Load More

Similar topics…

2026 Call – Short Study Stays in Europe

Jun 2, 2026

ELI is pleased to launch its 2026 call for short study stays in European lymphoma centers. 🔎 Key information: Objective: Promote education, training and collaboration in lymphoma care across Europe Who can apply: Early-career clinical physicians involved in lymphoma...

Workshop ELI 2026

Workshop ELI 2026

Feb 23, 2026

🌍 ELI Workshop 2026 – Bellinzona, Switzerland 📅 September 18–19, 2026 🧬 Focus: Marginal Zone Lymphoma We are pleased to announce our participation in the ELI Workshop 2026, taking place in Bellinzona, Switzerland, on September 18–19, 2026.This event will bring...

2025 Bertrand Coiffier Awards

Nov 17, 2025

The Bertrand Coiffier Prize 2025 was recently awarded to two promising young researchers: Dr. Amira Marouf (LYSA) and Dr. Nazarii Shokun (ELI). Prof. Marc André, President of the European Lymphoma Institute (ELI), and Prof. Franck Morschhauser, President of the...

See all news